Logo image of RECT

RECTITUDE HOLDINGS LTD (RECT) Stock Fundamental Analysis

NASDAQ:RECT - KYG7445R1011 - Common Stock

3.6 USD
-0.07 (-1.91%)
Last: 9/11/2025, 6:43:53 PM
Fundamental Rating

5

RECT gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 84 industry peers in the Commercial Services & Supplies industry. RECT has only an average score on both its financial health and profitability. RECT has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

RECT had positive earnings in the past year.
In the past year RECT had a positive cash flow from operations.
RECT Yearly Net Income VS EBIT VS OCF VS FCFRECT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 1M 2M 3M 4M

1.2 Ratios

RECT has a Return On Assets of 12.41%. This is amongst the best in the industry. RECT outperforms 90.48% of its industry peers.
RECT has a Return On Equity of 21.84%. This is amongst the best in the industry. RECT outperforms 88.10% of its industry peers.
RECT's Return On Invested Capital of 18.40% is amongst the best of the industry. RECT outperforms 94.05% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for RECT is above the industry average of 10.65%.
The last Return On Invested Capital (18.40%) for RECT is above the 3 year average (15.57%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 12.41%
ROE 21.84%
ROIC 18.4%
ROA(3y)9.53%
ROA(5y)N/A
ROE(3y)22.31%
ROE(5y)N/A
ROIC(3y)15.57%
ROIC(5y)N/A
RECT Yearly ROA, ROE, ROICRECT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 10 20 30

1.3 Margins

RECT's Profit Margin of 8.83% is amongst the best of the industry. RECT outperforms 80.95% of its industry peers.
RECT's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 11.08%, RECT is in the better half of the industry, outperforming 73.81% of the companies in the same industry.
In the last couple of years the Operating Margin of RECT has declined.
With a Gross Margin value of 36.03%, RECT perfoms like the industry average, outperforming 59.52% of the companies in the same industry.
In the last couple of years the Gross Margin of RECT has grown nicely.
Industry RankSector Rank
OM 11.08%
PM (TTM) 8.83%
GM 36.03%
OM growth 3Y-15.25%
OM growth 5YN/A
PM growth 3Y-9.79%
PM growth 5YN/A
GM growth 3Y4.69%
GM growth 5YN/A
RECT Yearly Profit, Operating, Gross MarginsRECT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 10 20 30

More info and screens

6

2. Health

2.1 Basic Checks

RECT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for RECT has been reduced compared to 1 year ago.
The debt/assets ratio for RECT has been reduced compared to a year ago.
RECT Yearly Shares OutstandingRECT Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 5M 10M
RECT Yearly Total Debt VS Total AssetsRECT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 4.90 indicates that RECT is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.90, RECT is in the better half of the industry, outperforming 76.19% of the companies in the same industry.
A Debt/Equity ratio of 0.14 indicates that RECT is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.14, RECT is doing good in the industry, outperforming 71.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 4.9
ROIC/WACC2.16
WACC8.54%
RECT Yearly LT Debt VS Equity VS FCFRECT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 5M 10M 15M 20M

2.3 Liquidity

RECT has a Current Ratio of 2.25. This indicates that RECT is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.25, RECT is doing good in the industry, outperforming 73.81% of the companies in the same industry.
A Quick Ratio of 1.62 indicates that RECT should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.62, RECT is doing good in the industry, outperforming 70.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.62
RECT Yearly Current Assets VS Current LiabilitesRECT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 5M 10M 15M 20M 25M

More info and screens

3

3. Growth

3.1 Past

RECT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -17.78%.
Measured over the past 5 years, RECT shows a small growth in Earnings Per Share. The EPS has been growing by 3.77% on average per year.
Looking at the last year, RECT shows a quite strong growth in Revenue. The Revenue has grown by 10.15% in the last year.
The Revenue has been growing by 13.68% on average over the past years. This is quite good.
EPS 1Y (TTM)-17.78%
EPS 3Y3.77%
EPS 5YN/A
EPS Q2Q%-14.81%
Revenue 1Y (TTM)10.15%
Revenue growth 3Y13.68%
Revenue growth 5YN/A
Sales Q2Q%9.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RECT Yearly Revenue VS EstimatesRECT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 10M 20M 30M 40M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.41 indicates a correct valuation of RECT.
Based on the Price/Earnings ratio, RECT is valued cheaper than 84.52% of the companies in the same industry.
When comparing the Price/Earnings ratio of RECT to the average of the S&P500 Index (27.44), we can say RECT is valued rather cheaply.
Industry RankSector Rank
PE 12.41
Fwd PE N/A
RECT Price Earnings VS Forward Price EarningsRECT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RECT indicates a somewhat cheap valuation: RECT is cheaper than 79.76% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.5
RECT Per share dataRECT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

The decent profitability rating of RECT may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RECT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RECTITUDE HOLDINGS LTD

NASDAQ:RECT (9/11/2025, 6:43:53 PM)

3.6

-0.07 (-1.91%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)07-31 2025-07-31
Earnings (Next)N/A N/A
Inst Owners0.11%
Inst Owner ChangeN/A
Ins Owners83.45%
Ins Owner ChangeN/A
Market Cap52.20M
AnalystsN/A
Price TargetN/A
Short Float %0.21%
Short Ratio2.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 12.41
Fwd PE N/A
P/S 1.08
P/FCF N/A
P/OCF 334.79
P/B 2.68
P/tB 2.68
EV/EBITDA 7.5
EPS(TTM)0.29
EY8.06%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.01
OCFY0.3%
SpS3.32
BVpS1.34
TBVpS1.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.41%
ROE 21.84%
ROCE 21.41%
ROIC 18.4%
ROICexc 23.23%
ROICexgc 23.23%
OM 11.08%
PM (TTM) 8.83%
GM 36.03%
FCFM N/A
ROA(3y)9.53%
ROA(5y)N/A
ROE(3y)22.31%
ROE(5y)N/A
ROIC(3y)15.57%
ROIC(5y)N/A
ROICexc(3y)18.49%
ROICexc(5y)N/A
ROICexgc(3y)18.49%
ROICexgc(5y)N/A
ROCE(3y)18.11%
ROCE(5y)N/A
ROICexcg growth 3Y-21.08%
ROICexcg growth 5YN/A
ROICexc growth 3Y-21.08%
ROICexc growth 5YN/A
OM growth 3Y-15.25%
OM growth 5YN/A
PM growth 3Y-9.79%
PM growth 5YN/A
GM growth 3Y4.69%
GM growth 5YN/A
F-Score5
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA 0.39
Cap/Depr 32.63%
Cap/Sales 1%
Interest Coverage 28.54
Cash Conversion 2.29%
Profit Quality N/A
Current Ratio 2.25
Quick Ratio 1.62
Altman-Z 4.9
F-Score5
WACC8.54%
ROIC/WACC2.16
Cap/Depr(3y)16.41%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.67%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.78%
EPS 3Y3.77%
EPS 5YN/A
EPS Q2Q%-14.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.15%
Revenue growth 3Y13.68%
Revenue growth 5YN/A
Sales Q2Q%9.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.18%
EBIT growth 3Y-3.65%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-110.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-95.24%
OCF growth 3Y-46.74%
OCF growth 5YN/A